Inclusion Criteria:~* Has mild to moderate AD dementia based on the national institute of neurological and
communicative diseases and stroke/Alzheimer's Disease and related disorders association (NINCDS-ADRDA)
criteria.~* Has mini-mental state examination (MMSE) score between 12-22 (inclusive) at screening.~* Is using
acetylcholinesterase inhibitors (AChEI) therapy for management of AD dementia at Screening and during the
study. These medications must be at stable approved dose levels â‰¥3 months before the first dose of study
intervention and the regimens must remain constant throughout the study to the extent that is clinically
appropriate.~* Has a designated study partner who can fulfill the requirements of this study. The study partner
will need to spend sufficient time with the participant to be familiar with their overall function and behavior
and be able to provide adequate information about the participant needed for the study including, knowledge of
functional and basic activities of daily life, work/educational history, cognitive performance,
emotional/psychological state, and general health status.~
